€ million |
|
Capital |
|
Capital reserves |
|
Retained earnings incl. net income |
|
Exchange differences |
|
Fair-value measurement of equity instruments |
|
Cash flow hedges |
|
Equity attributable to Bayer AG stockholders |
|
Equity attributable to noncontrolling interest |
|
Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 1, 2024 |
|
2,515 |
|
18,261 |
|
12,175 |
|
(128) |
|
81 |
|
23 |
|
32,927 |
|
151 |
|
33,078 |
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income after income taxes |
|
|
|
|
|
(2,552) |
|
|
|
|
|
|
|
(2,552) |
|
6 |
|
(2,546) |
Other comprehensive income |
|
|
|
|
|
370 |
|
1,385 |
|
(75) |
|
(86) |
|
1,594 |
|
3 |
|
1,597 |
Miscellaneous other changes |
|
|
|
|
|
(65) |
|
|
|
10 |
|
55 |
|
|
|
|
|
|
Equity transactions with owners |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend payments |
|
|
|
|
|
(108) |
|
|
|
|
|
|
|
(108) |
|
(23) |
|
(131) |
Other changes |
|
|
|
|
|
47 |
|
|
|
|
|
|
|
47 |
|
|
|
47 |
Dec. 31, 2024 |
|
2,515 |
|
18,261 |
|
9,867 |
|
1,257 |
|
16 |
|
(8) |
|
31,908 |
|
137 |
|
32,045 |
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income after income taxes |
|
|
|
|
|
(3,620) |
|
|
|
|
|
|
|
(3,620) |
|
25 |
|
(3,595) |
Other comprehensive income |
|
|
|
|
|
595 |
|
(2,879) |
|
(27) |
|
19 |
|
(2,292) |
|
(27) |
|
(2,319) |
Miscellaneous other changes |
|
|
|
|
|
(67) |
|
|
|
5 |
|
62 |
|
|
|
|
|
|
Equity transactions with owners |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend payments |
|
|
|
|
|
(108) |
|
|
|
|
|
|
|
(108) |
|
(19) |
|
(127) |
Other changes |
|
|
|
|
|
59 |
|
|
|
|
|
|
|
59 |
|
|
|
59 |
Dec. 31, 2025 |
|
2,515 |
|
18,261 |
|
6,726 |
|
(1,622) |
|
(6) |
|
73 |
|
25,947 |
|
116 |
|
26,063 |